Stereoisomers in psychiatry: The case of escitalopram

Primary Care Companion to the Journal of Clinical Psychiatry

Volumn 4, Issue 1, 2002, Pages 20-24

  Burke, William J ^a,b   Kratochvil, Christopher J ^a  

^a UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 1842606258     PISSN: 15235998     EISSN: None     Source Type: Journal    
DOI: 10.4088/pcc.v04n0107     Document Type: Article

References (18)

1. Brocks DR, Jamali F. Stereochemical aspects of pharmacotherapy. Pharmacotherapy 1995;15:551-564
2. Pennisi E. Parasitology. Close encounters: good, bad, and ugly. Science 2000;290:1491-1493
3. Hull AJ, Tan SC. Drug chirality and its clinical significance. Drugs 1996;52(suppl 5):1-12
4. Eichelbaum M. Enantiomers: implications and complications in developmental pharmacology. Dev Pharmacol Ther 1992;18:131-134
5. Wainer IW. Three-dimensional view of pharmacology. Am J Hosp Pharm 1992;49(9, suppl 1):S4-S8
6. Caldwell J. Stereochemical determinants of the nature and consequences of drug metabolism. J Chromatogr A 1995;694:39-48
7. Tucker GT. Chiral switches. Lancet 2000;355:1085-1087
8. Lane RM, Baker GB. Chirality and drugs used in psychiatry: nice to know or need to know? Cell Mol Neurobiol 1999;19:355-372
9. Baumann P, Rochat B. Comparative pharmacokinetics of selective serotonin reuptake inhibitors: a look behind the mirror. Int Clin Psychopharmacol 1995;10(suppl 1):15-21
10. Owens MJ, Knight DL, Nemeroff CB. Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine. Biol Psychiatry 2001;50:345-350
11. Hyttel J, Bøges KP, Perregaard J, et al. The pharmacological effect of citalopram resides in the (S)-(+)-enantiomer, J Neural Transm Gen Sect 1992;88:157-160
12. Rochat B, Amey M, Baumann P. Analysis of enantiomers of citalopram and its demethylated metabolites in plasma of depressive patients using chiral reverse-phase liquid chromatography. Ther Drug Monit 1995;17:273-279
13. Sanchez C, Hyttel J. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding. Cell Mol Neurobiol 1999;19:467-489
14. Mitchell PJ, Hogg S. Beavioural effects of escitalopram predict potent antidepressant activity. Presented at the 7th World Congress of Biological Psychiatry; July 1-6, 2001; Berlin, Germany
15. Sanchez C, Hogg S. The antidepressant effect of citalopram resides in the S-enantiomer (Lu 26-054). Presented at the 55th annual meeting of the Society of Biological Psychiatry: May 11-13, 2000; Chicago, Ill
16. Mitchell P, Hogg S. Escitalopram: rapid antidepressant activity in rats. Presented at the 7th World Congress of Biological Psychiatry; July 1-6. 2001; Berlin, Germany
17. Burke WJ, Gergel I, Bose A. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients. J Clin Psychiatry 2002;63:331-336
18. Gorman JM, Korotzer A, Su G. Efficacy comparison of escitalopram and citalopram in the treatment of major depressive disorder: pooled analysis of placebo-controlled trials. CNS Spectrums 2002;7(suppl 1):40-44